Biblio

[ Author(Asc)] Title Type Year
Filters: Author is Chen, Xi  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Chen X, Yan J, He F, Zhong D, Yang H, Pei M, Luo Z-P. Mechanical stretch induces antioxidant responses and osteogenic differentiation in human mesenchymal stem cells through activation of the AMPK-SIRT1 signaling pathway. Free Radic Biol Med. 2018.
Chen X, Lin H, Yang D, Xu W, Liu G, Liu X, Sheng J, Huang H. Early life undernutrition reprograms CD4 T-cell glycolysis and epigenetics to facilitate asthma. J Allergy Clin Immunol. 2019.
Chen X, Cao Y, Sedhom W, Lu L, Liu Y, Wang H, Oka M, Bornstein S, Said S, Song J, et al. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma. Mol Oncol. 2019.
Chen X, Sun K, Zhao S, Geng T, Fan X, Sun S, Zheng M, Jin Q. Irisin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by activating autophagy via the Wnt//β-catenin signal pathway. Cytokine. 2020;136:155292.
Chen X, Sun J, Li X. Adipose derived stem cells to construct parathyroid organoid for hypoparathyroidism. Med Hypotheses. 2021;149:110540.
Chen X, Fan Y, Sun J, Zhang Z, Xin Y, Li K, Tang K, Du P, Liu Y, Wang G, et al. Nanoparticle-mediated specific elimination of soft cancer stem cells by targeting low cell stiffness. Acta Biomater. 2021.
Chen X, Adhikary G, Newland JJ, Xu W, Keillor JW, Weber DJ, Eckert RL. Transglutaminase 2 binds to the CD44v6 cytoplasmic domain to stimulate CD44v6/ERK1/2 signaling and maintain an aggressive cancer phenotype. Mol Cancer Res. 2023.
Chen X, Chen Y, Li C, Li J, Zhang S, Liang C, Deng Q, Guo Z, Guo C, Yan H. Glutaredoxin 2 protects lens epithelial cells from epithelial-mesenchymal transition by suppressing mitochondrial oxidative stress-related upregulation of integrin-linked kinase. Exp Eye Res. 2023:109609.
Chen X, Lu N, Huang S, Zhang Y, Liu Z, Wang X. Assessment of doxorubicin toxicity using human cardiac organoids: A novel model for evaluating drug cardiotoxicity. Chem Biol Interact. 2023:110777.
Chen X, Xu Z, Li T, Thakur A, Wen Y, Zhang K, Liu Y, Liang Q, Liu W, Qin J-J, et al. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy. Biomark Res. 2024;12(1):2.
Chen X, Liu X, He H, Guo X, Li S, Huang Y, Wang X, She H. Stem cell factor protects against chronic ischemic retinal injury by modulating on neurovascular unit. Biomed Pharmacother. 2024;173:116318.